Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation.

Subjects

Subjects :

*MULTIPLE myeloma
*CELLULAR therapy
*BRAF genes
*MITOGEN-activated protein kinases
*CD38 antigen

Details

Language :

English

ISSN :

17568722

Volume :

16

Issue :

1

Database :

Academic Search Index

Journal :

Journal of Hematology & Oncology

Publication Type :

Academic Journal

Accession number :

163613660

Full Text :

https://doi.org/10.1186/s13045-023-01449-x